S 2081
116th Congress
Senate
Health
Government information and archives
Government trust funds
Health care costs and insurance
Home and outpatient care
Inflation and prices
Manufacturing
Medicare
Prescription drugs
Stop Drug Companies from Overcharging Seniors in Medicare Part B Act of 2019
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jul 10, 2019
Read twice and referred to the Committee on Finance.
Jul 10, 2019
Introduced in Senate
Plain-English summary
Stop Drug Companies from Overcharging Seniors in Medicare Part B Act of 2019
This bill requires manufacturers of covered drugs under Medicare medical services to issue rebates to the Centers for Medicare & Medicaid Services. Rebates are calculated based on the number of units sold and the amount by which the manufacturer price exceeds inflation. The bill's requirements do not apply to drugs that cost less than $100 annually per user in 2020 (and as adjusted for inflation annually thereafter) or to drugs on a specified drug shortage list.
The bill also eliminates cost-sharing for such drugs for beneficiaries whose out-of-pocket costs meet or exceed a specified threshold.
What's happening now
Read twice and referred to the Committee on Finance.
Committees of jurisdiction
1